Literature DB >> 31197065

Associations between vaginal bacteria implicated in HIV acquisition risk and proinflammatory cytokines and chemokines.

Michelle C Sabo1, Dara A Lehman2,3, Bingjie Wang4, Barbra A Richardson3,5,6, Sujatha Srinivasan2, Lusi Osborn7, Daniel Matemo7, John Kinuthia3,8, Tina L Fiedler2, Matthew M Munch2, Alison L Drake3, David N Fredricks2, Julie Overbaugh4, Grace John-Stewart9,3,5,10, R Scott McClelland9,3,5,8, Susan M Graham9,3,5.   

Abstract

OBJECTIVES: Recent studies have identified vaginal bacterial taxa associated with increased HIV risk. A possible mechanism to explain these results is that individual taxa differentially promote cervicovaginal inflammation. This study aimed to explore relationships between concentrations of bacteria previously linked to HIV acquisition and vaginal concentrations of proinflammatory cytokines and chemokines.
METHODS: In this cross-sectional analysis, concentrations of 17 bacterial taxa and four proinflammatory cytokines (interleukin (IL)-1β, IL-6, IL-10 and tumour necrosis factor alpha (TNFα)) and two proinflammatory chemokines (IL-8 and interferon gamma-induced protein 10) were measured in vaginal swabs collected from 80 HIV-uninfected women. Cytokine and chemokine concentrations were compared between women with bacterial concentrations above or below the lower limit of detection as determined by quantitative PCR for each taxon. Principal component analysis was used to create a summary score for closely correlated bacteria, and linear regression analysis was used to evaluate associations between this score and increasing concentrations of TNFα and IL-1β.
RESULTS: Detection of Dialister micraerophilus (p=0.01), Eggerthella sp type 1 (p=0.05) or Mycoplasma hominis (p=0.03) was associated with higher TNFα concentrations, and detection of D. micraerophilus (p<0.01), Eggerthella sp type 1 (p=0.04), M. hominis (p=0.02) or Parvimonas sp type 2 (p=0.05) was associated with significantly higher IL-1β concentrations. Seven bacterial taxa (D. micraerophilus, Eggerthella sp type 1, Gemella asaccharolytica, Sneathia sp, Megasphaera sp, M. hominis and Parvimonas sp type 2) were found to be highly correlated by principal component analysis (eigenvalue 5.24, explaining 74.92% of variability). Linear regression analysis demonstrated associations between this principal component and concentrations of TNFα (β=0.55, 95% CI 0.01 to 1.08; p=0.048) and IL-1β (β=0.96, 95% CI 0.19 to 1.74; p=0.016).
CONCLUSIONS: This study provides evidence that several highly correlated vaginal bacterial taxa may influence vaginal cytokine and chemokine concentrations. These results suggest a mechanism where the presence of specific bacterial taxa could influence HIV susceptibility by increasing vaginal inflammation. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  HIV women; Trichomonas; immunology; sexual health; vaginal microbiology

Mesh:

Substances:

Year:  2019        PMID: 31197065      PMCID: PMC6920574          DOI: 10.1136/sextrans-2018-053949

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  31 in total

1.  Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.

Authors:  David N Fredricks; Tina L Fiedler; Katherine K Thomas; Caroline M Mitchell; Jeanne M Marrazzo
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

2.  Genital inflammation and the risk of HIV acquisition in women.

Authors:  Lindi Masson; Jo-Ann S Passmore; Lenine J Liebenberg; Lise Werner; Cheryl Baxter; Kelly B Arnold; Carolyn Williamson; Francesca Little; Leila E Mansoor; Vivek Naranbhai; Douglas A Lauffenburger; Katharina Ronacher; Gerhard Walzl; Nigel J Garrett; Brent L Williams; Mara Couto-Rodriguez; Mady Hornig; W Ian Lipkin; Anneke Grobler; Quarraisha Abdool Karim; Salim S Abdool Karim
Journal:  Clin Infect Dis       Date:  2015-04-21       Impact factor: 9.079

3.  Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion.

Authors:  Charles Morrison; Raina N Fichorova; Chris Mauck; Pai-Lien Chen; Cynthia Kwok; Tsungai Chipato; Robert Salata; Gustavo F Doncel
Journal:  J Acquir Immune Defic Syndr       Date:  2014-06-01       Impact factor: 3.731

4.  High levels of tumor necrosis factor-alpha and interleukin-1beta in bacterial vaginosis may increase susceptibility to human immunodeficiency virus.

Authors:  K Sturm-Ramirez; A Gaye-Diallo; G Eisen; S Mboup; P J Kanki
Journal:  J Infect Dis       Date:  2000-07-18       Impact factor: 5.226

5.  Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Authors:  Jordan K Kyongo; Tania Crucitti; Joris Menten; Liselotte Hardy; Piet Cools; Johan Michiels; Sinead Delany-Moretlwe; Mary Mwaura; Gilles Ndayisaba; Sarah Joseph; Raina Fichorova; Janneke van de Wijgert; Guido Vanham; Kevin K Ariën; Vicky Jespers
Journal:  Clin Vaccine Immunol       Date:  2015-03-11

6.  Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation.

Authors:  Aisha Nazli; Olivia Chan; Wendy N Dobson-Belaire; Michel Ouellet; Michel J Tremblay; Scott D Gray-Owen; A Larry Arsenault; Charu Kaushic
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

7.  Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis.

Authors:  T L Cherpes; J M Marrazzo; L A Cosentino; L A Meyn; P J Murray; S L Hillier
Journal:  Sex Transm Infect       Date:  2007-10-02       Impact factor: 3.519

8.  A 15-year study of the impact of community antiretroviral therapy coverage on HIV incidence in Kenyan female sex workers.

Authors:  R Scott McClelland; Barbra A Richardson; Peter Cherutich; Kishorchandra Mandaliya; Grace John-Stewart; Benard Miregwa; Katherine Odem-Davis; Walter Jaoko; Davies Kimanga; Julie Overbaugh
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

Review 9.  Bacterial vaginosis and the cervicovaginal immune response.

Authors:  Caroline Mitchell; Jeanne Marrazzo
Journal:  Am J Reprod Immunol       Date:  2014-06       Impact factor: 3.886

10.  Impact of Standard Bacterial Vaginosis Treatment on the Genital Microbiota, Immune Milieu, and Ex Vivo Human Immunodeficiency Virus Susceptibility.

Authors:  Vineet Joag; Onyango Obila; Pawel Gajer; Milcah Carol Scott; Sara Dizzell; Michael Humphrys; Kamnoosh Shahabi; Sanja Huibner; Brett Shannon; Wangari Tharao; Marianne Mureithi; Julius Oyugi; Joshua Kimani; Charu Kaushic; Jacques Ravel; Omu Anzala; Rupert Kaul
Journal:  Clin Infect Dis       Date:  2019-05-02       Impact factor: 9.079

View more
  10 in total

1.  Genital microbiota of women using a 90 day tenofovir or tenofovir and levonorgestrel intravaginal ring in a placebo controlled randomized safety trial in Kenya.

Authors:  Smritee Dabee; Nelly Mugo; Victor Mudhune; Eleanor McLellan-Lemal; Sue Peacock; Siobhan O'Connor; Betty Njoroge; Beatrice Nyagol; Andrea R Thurman; Eunice Ouma; Renee Ridzon; Jeffrey Wiener; Harald S Haugen; Melanie Gasper; Colin Feng; Shannon A Allen; Gustavo F Doncel; Heather B Jaspan; Renee Heffron
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

2.  Impact of Dapivirine and Placebo Vaginal Rings on the Microbiota of Adolescent, Lactating, and Postmenopausal Females.

Authors:  Michele N Austin; Leslie A Meyn; Hilary A Avolia; Melinda A Petrina; Lisa A Cosentino; Calins Alphonse; Beatrice A Chen; Katherine Bunge; Lisa Noguchi; Richard Beigi; Kathleen Squires; Sharon L Hillier
Journal:  J Infect Dis       Date:  2022-06-15       Impact factor: 7.759

Review 3.  Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes.

Authors:  Kevin R Theis; Violetta Florova; Roberto Romero; Andrei B Borisov; Andrew D Winters; Jose Galaz; Nardhy Gomez-Lopez
Journal:  Crit Rev Microbiol       Date:  2021-04-06       Impact factor: 7.624

4.  Clinical Manifestations of Polycystic Ovary Syndrome and Associations With the Vaginal Microbiome: A Cross-Sectional Based Exploratory Study.

Authors:  Xiang Hong; Pengfei Qin; Jiechen Yin; Yong Shi; Yan Xuan; Zhengqi Chen; Xu Zhou; Hong Yu; Danhong Peng; Bei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

5.  Elevation of cervical C-X-C motif chemokine ligand 10 levels is associated with HIV-1 acquisition in pregnant and postpartum women.

Authors:  Michelle C Sabo; Dara A Lehman; Jillian C Pintye; Bingjie Wang; Alison L Drake; John Kinuthia; Lusi Osborn; Daniel Matemo; Barbra A Richardson; Julie Overbaugh; Grace John-Stewart; Susan M Graham
Journal:  AIDS       Date:  2020-10-01       Impact factor: 4.632

6.  Elevated levels of inflammatory plasma biomarkers are associated with risk of HIV infection.

Authors:  Samantha McInally; Kristin Wall; Tianwei Yu; Rabindra Tirouvanziam; William Kilembe; Jill Gilmour; Susan A Allen; Eric Hunter
Journal:  Retrovirology       Date:  2021-03-17       Impact factor: 4.602

7.  Unique roles of vaginal Megasphaera phylotypes in reproductive health.

Authors:  Abigail L Glascock; Nicole R Jimenez; Sam Boundy; Vishal N Koparde; J Paul Brooks; David J Edwards; Jerome F Strauss Iii; Kimberly K Jefferson; Myrna G Serrano; Gregory A Buck; Jennifer M Fettweis
Journal:  Microb Genom       Date:  2021-12

Review 8.  Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis.

Authors:  Antonio Barrientos-Durán; Ana Fuentes-López; Adolfo de Salazar; Julio Plaza-Díaz; Federico García
Journal:  Nutrients       Date:  2020-02-06       Impact factor: 5.717

Review 9.  Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Authors:  Ross Cromarty; Derseree Archary
Journal:  AIDS Res Treat       Date:  2020-10-27

Review 10.  Human genital tracts microbiota: dysbiosis crucial for infertility.

Authors:  M A Venneri; E Franceschini; F Sciarra; E Rosato; G D'Ettorre; A Lenzi
Journal:  J Endocrinol Invest       Date:  2022-02-03       Impact factor: 5.467

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.